Literature DB >> 19932795

Frequency of cardiac death in children with idiopathic dilated cardiomyopathy.

V Vivian Dimas1, Susan W Denfield, Richard A Friedman, Bryan C Cannon, Jeffrey J Kim, E O 'brian Smith, Sarah K Clunie, Jack F Price, Jeffrey A Towbin, William J Dreyer, Naomi J Kertesz.   

Abstract

The prognosis in children with idiopathic dilated cardiomyopathy (IDC) is guarded, with the 5-year mortality rate ranging from 14% to 50%, owing to sudden cardiac death (SCD) or pump failure. The risk factors for SCD in adults with IDC include asymptomatic nonsustained ventricular tachycardia and poor left ventricular function. It is unclear whether these findings can be extrapolated to the pediatric population. A retrospective review of all patients with the diagnosis of IDC seen at a single institution from 1990 to 2004 was performed. A total of 85 patients (46 males), with a median age of 3.8 years (0 days to 17.3 years) were studied. The mean left ventricular ejection fraction was 25 +/- 12% (median 23%, range 45% to 45%) at presentation. The following arrhythmias occurred at presentation or during the initial hospitalization: nonsustained ventricular tachycardia in 6, sustained ventricular tachycardia or fibrillation in 1, supraventricular arrhythmias in 6, and both atrial and ventricular arrhythmias in 1. During a subsequent hospitalization or outpatient follow-up, 7 patients had the following arrhythmias: supraventricular arrhythmias in 2, nonsustained ventricular tachycardia in 4, and both atrial and ventricular arrhythmias in 1. The cumulative survival rate was 40% at a mean follow-up of 6.2 years (95% confidence interval 4.4 to 8.1). One single episode of SCD occurred in 1 patient without a history of sustained arrhythmias. In conclusion, in children with IDC, despite the low left ventricular ejection fraction and presence of ventricular arrhythmias, only one episode of SCD occurred in this group of patients. Given the 1% incidence of SCD in this cohort, the use of implantable cardioverter-defibrillators as primary prevention in children with IDC might not be indicated.

Entities:  

Mesh:

Year:  2009        PMID: 19932795     DOI: 10.1016/j.amjcard.2009.07.034

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry.

Authors:  Elfriede Pahl; Lynn A Sleeper; Charles E Canter; Daphne T Hsu; Minmin Lu; Steven A Webber; Steven D Colan; Paul F Kantor; Melanie D Everitt; Jeffrey A Towbin; John L Jefferies; Beth D Kaufman; James D Wilkinson; Steven E Lipshultz
Journal:  J Am Coll Cardiol       Date:  2012-02-07       Impact factor: 24.094

2.  Dilated cardiomyopathy in a national paediatric population.

Authors:  Muhammad Bassem Jammal Addin; David Young; Sarah McCarrison; Lindsey Hunter
Journal:  Eur J Pediatr       Date:  2019-06-11       Impact factor: 3.183

3.  The relationship between electrocardiographic data and mortality in children diagnosed with dilated cardiomyopathy.

Authors:  Mehmet Türe; Hasan Balık; Alper Akın; Meki Bilici; Ahmet Nergiz
Journal:  Eur J Pediatr       Date:  2020-01-14       Impact factor: 3.183

4.  Acute isoproterenol leads to age-dependent arrhythmogenesis in guinea pigs.

Authors:  Kathleen C Woulfe; Cortney E Wilson; Shane Nau; Sarah Chau; Elisabeth K Phillips; Shulun Zang; Christine Tompkins; Carmen C Sucharov; Shelley D Miyamoto; Brian L Stauffer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

5.  Development of Antiarrhythmic Therapy-Resistant Ventricular Tachycardia, Ventricular Fibrillation, and Premature Ventricular Contractions in a 15-Year-Old Patient.

Authors:  Can Yilmaz Yozgat; Osman Yesilbas; Akin Iscan; Ismail Yurtsever; Hafize Otcu Temur; Nigar Bayramova; Gokce Ergun; Nur Tekin; Yilmaz Yozgat
Journal:  J Pediatr Intensive Care       Date:  2020-09-28

Review 6.  Stem cell therapy for pediatric dilated cardiomyopathy.

Authors:  Sarah M Selem; Sunjay Kaushal; Joshua M Hare
Journal:  Curr Cardiol Rep       Date:  2013-06       Impact factor: 2.931

7.  The Cardiac Microenvironment Instructs Divergent Monocyte Fates and Functions in Myocarditis.

Authors:  Xuezhou Hou; Guobao Chen; William Bracamonte-Baran; Hee Sun Choi; Nicola L Diny; Jungeun Sung; David Hughes; Taejoon Won; Megan Kay Wood; Monica V Talor; David Joel Hackam; Karin Klingel; Giovanni Davogustto; Heinrich Taegtmeyer; Isabelle Coppens; Jobert G Barin; Daniela Čiháková
Journal:  Cell Rep       Date:  2019-07-02       Impact factor: 9.423

8.  Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy.

Authors:  Lei Wu; SuFey Ong; Monica V Talor; Jobert G Barin; G Christian Baldeviano; David A Kass; Djahida Bedja; Hao Zhang; Asfandyar Sheikh; Joseph B Margolick; Yoichiro Iwakura; Noel R Rose; Daniela Ciháková
Journal:  J Exp Med       Date:  2014-06-16       Impact factor: 14.307

Review 9.  The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology.

Authors:  Lee A Meier; Bryce A Binstadt
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.